Show Notes
The UK government has said it will introduce a ‘Pharmacy First’ service for England by the end of 2023, as part of a plan for recovering access to primary care.
Negotiations are ongoing, but the new service is designed to enable pharmacists to supply medicines for seven common health conditions, including earache, sore throat and urinary tract infections. However, it is not clear whether community pharmacies have the capacity to take on such a large new NHS service and some academics are warning of the potential for “extremely serious” consequences for antimicrobial resistance.
In this episode, executive editor Nigel Praities and investigations editor Carolyn Wickware take a closer look at the plans and the main stumbling blocks to the service’s implementation by the end of 2023.
More information regarding the independent prescribing pilots mentioned in the episode can be found here: https://pharmaceutical-journal.com/article/news/all-integrated-health-boards-in-england-submit-bids-for-pharmacy-independent-prescribing-services
This episode was produced by Geoff Marsh.
More from The PJ Pod
For Tase Oputu, becoming the first president of the Royal College of Pharmacy is “the greatest honour of my career”, and she says the move to a royal college is already changing how pharmacy is received by policymakers.
In this episode of Pharmacy Inside Jobs, senior editor, research and learning Alex Clabburn talks to Ed Hindle.
Electronic Prescription System (EPS) nominations connect patients with the pharmacy where they can collect their medication – and often access other services, help and advice while they’re there.
In this episode of Pharmacy Inside Jobs, Joanna Robertson, senior clinical reporter, talks to Mark Stuart, a sports pharmacist whose 25-year career has spanned Olympic, Paralympic and Commonwealth games, as well as anti-doping education at the International Testing Agency.
In this episode of The PJ Pod, senior features editor Siobhan Chan examines how the issue of antimicrobial resistance (AMR) is being communicated outside of traditional clinical and policy settings.